TMCnet News

Medicinal Genomics Corporation Launches SenSATIVAx™ A Novel, Automated Plant / Microbial DNA Purification Kit for Cannabis
[March 31, 2015]

Medicinal Genomics Corporation Launches SenSATIVAx™ A Novel, Automated Plant / Microbial DNA Purification Kit for Cannabis


Medicinal Genomics Corporation, a pioneer in the genomics of medicinal plants, today announced the availability of SenSATIVAx™, a highly robust and automated microbial DNA purification kit for Cannabis.

SenSATIVAx™ is a proprietary DNA isolation chemistry that uses magnetic microparticles to isolate and purify both plant and microbial DNA from a raw homogenized sample. SenSATIVAx is a highly effective and extremely efficient DNA purification system that can be automated using a 96-well head robot. DNA can be isolated from a single sample or a large batch in less than 30 minutes. The core magnetic particle technology inside of SenSATIVAx™ is one of the most efficient and effective DNA purification chemistries that was utilized by scientists who worked on the Human Genome Project.

"We see a continued customer need to have improved methods for isolating and purifying DNA from Cannabis. The SenSATIVAx™ Plant / Microbial DNA Purification Kit addresses this by providing significantly improved DNA recovery in a scalable and automated processing format, enabling researchers to streamline their up-front sample preparation. High quality DNA that isfree of cannabinoids, and is PCR (News - Alert) and Next Generation Sequencing compatible, is the first step in being able to rapidly share the genetics of the plant," stated Kevin McKernan, Medicinal Genomics Chief Scientific Officer.



Jessica Tonani, CEO of Verda Bio stated: "Medicinal Genomics' SenSATIVAx™ Plant / Microbial DNA Purification Kit is quick and easy to use, requires minimal equipment, and produces a high quality purified DNA. These samples perform well in a variety of genomic applications, including microbial safety testing and research into plant genetics."

Michael Kahn, CEO of MCR Labs states: "We are using the Medicinal Genomics platform in all our microbiological contaminants testing. SenSATIVAx™ is a brilliant, scalable technology, and MGC is a reliable partner."


About Medicinal Genomics

Medicinal Genomics Corporation applies state-of-the-art life science technology to Cannabis plant genetics. Our products help growers, dispensaries, and quality-testing labs characterize and understand the quality and safety of medicinal Cannabis. Medicinal Genomics utilizes a highly sophisticated Next Generation Sequencing laboratory, proprietary bioinformatics system, and DNA based technologies to deliver unmatched technical solutions to decipher the genetic code and quality level of medicinal Cannabis. Medicinal Genomics is a wholly owned subsidiary of Courtagen Life Sciences, Inc.

About Courtagen Life Sciences Inc.

Courtagen Life Sciences, Inc., located in Woburn, MA, is a CLIA/CAP certified molecular information company focused on the diagnosis of a range of neurological disorders. Courtagen operates a highly sophisticated state-of-the-art Next-Generation DNA Sequencing, Bioinformatics, and clinical interpretation business. Courtagen's work helps physicians elucidate the linkages between the genotypes and phenotypes of various neurological diseases.


[ Back To TMCnet.com's Homepage ]